Suppr超能文献

转基因和基因组编辑生物的新应用给欧盟上市后环境监测带来的挑战。

Challenges for the Post-Market Environmental Monitoring in the European Union Imposed by Novel Applications of Genetically Modified and Genome-Edited Organisms.

作者信息

Dolezel Marion, Lang Andreas, Greiter Anita, Miklau Marianne, Eckerstorfer Michael, Heissenberger Andreas, Willée Eva, Züghart Wiebke

机构信息

Land Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.

Büro Lang, Hoernlehof, Gresgen 108, 79669 Zell im Wiesental, Germany.

出版信息

BioTech (Basel). 2024 May 15;13(2):14. doi: 10.3390/biotech13020014.

Abstract

Information on the state of the environment is important to achieve the objectives of the European Green Deal, including the EU's Biodiversity Strategy for 2030. The existing regulatory provisions for genetically modified organisms (GMOs) foresee an obligatory post-market environmental monitoring (PMEM) of potential adverse effects upon release into the environment. So far, GMO monitoring activities have focused on genetically modified crops. With the advent of new genomic techniques (NGT), novel GMO applications are being developed and may be released into a range of different, non-agricultural environments with potential implications for ecosystems and biodiversity. This challenges the current monitoring concepts and requires adaptation of existing monitoring programs to meet monitoring requirements. While the incorporation of existing biodiversity monitoring programs into GMO monitoring at the national level is important, additional monitoring activities will also be required. Using case examples, we highlight that monitoring requirements for novel GMO applications differ from those of GM crop plants previously authorized for commercial use in the European Union.

摘要

环境状况信息对于实现欧洲绿色协议的目标至关重要,包括欧盟2030年生物多样性战略。现有的转基因生物监管规定预见了对释放到环境中的潜在不利影响进行强制性上市后环境监测(PMEM)。到目前为止,转基因生物监测活动主要集中在转基因作物上。随着新基因组技术(NGT)的出现,新型转基因生物应用正在开发中,并可能释放到一系列不同的非农业环境中,对生态系统和生物多样性产生潜在影响。这对当前的监测概念提出了挑战,需要调整现有监测计划以满足监测要求。虽然将现有的生物多样性监测计划纳入国家层面的转基因生物监测很重要,但也需要额外的监测活动。通过案例,我们强调新型转基因生物应用的监测要求与先前在欧盟获得商业使用授权的转基因作物的监测要求不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fdd/11130885/8cff9207f82f/biotech-13-00014-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验